Analytical Data
-
Gene name
FAM108A1
- Application
-
Alternative Names
ABHD17A; C19orf27; FAM108A1Alpha/beta hydrolase domain-containing protein 17A; Abhydrolase domain-containing protein 17A; EC 3.1.2.22
-
Species
Human
-
Source
E. coli
-
Tag
GST-tag at N-terminal
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
Q96GS6
-
Expression Region
21-310aa
-
AA Sequence
RIAAKLAFLP PEATYSLVPE PEPGPGGAGA APLGTLRASS GAPGRWKLHL TERADFQYSQ RELDTIEVFP TKSARGNRVS CMYVRCVPGA RYTVLFSHGN AVDLGQMSSF YIGLGSRLHC NIFSYDYSGY GASSGRPSER NLYADIDAAW QALRTRYGIS PDSIILYGQS IGTVPTVDLA SRYECAAVVL HSPLTSGMRV AFPDTKKTYC FDAFPNIEKV SKITSPVLII HGTEDEVIDF SHGLALYERC PKAVEPLWVE GAGHNDIELY SQYLERLRRF ISQELPSQRA
-
Molecular Weight
33.9 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
FAM108A1, also known as Family with Sequence Similarity 108 Member A1, is a protein encoded by the FAM108A1 gene, which has garnered attention due to its potential role in various biological processes and diseases. Initially identified through genomic studies, FAM108A1 is believed to be involved in cellular functions such as cell proliferation, differentiation, and apoptosis. Research has suggested that alterations in FAM108A1 expression levels may be linked to certain cancers and neurodegenerative diseases, highlighting its potential as a biomarker for disease progression or therapeutic targets. The study of recombinant FAM108A1 protein aims to elucidate its structure-function relationships and interaction networks within the cellular context, which can provide insights into the molecular mechanisms underlying its involvement in disease. Additionally, constructing and characterizing recombinant forms of FAM108A1 can facilitate functional assays and drug discovery efforts. Understanding the biochemical properties and biological roles of this protein is critical for developing novel therapeutic strategies and improving outcomes for patients with diseases associated with FAM108A1 dysregulation. As such, ongoing research efforts are focused on the production and analysis of recombinant FAM108A1 to explore its potential implications in health and disease.
